CRP and cardiovascular disorder: Recently, the neutrophil-to-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and C-reactive protein-to-albumin ratio (CAR) have been suggested as useful and cost-effective prognostic biomarkers in various diseases, including malignant and cardiovascular diseases [10–12].